Matt McKevitt

A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus Infection of the Lower Respiratory Tract

Francisco M. Marty, Roy F. Chemaly, Kathleen M. Mullane et al. · Clinical Infectious Diseases · 2019 · 76 citations · Full text

Life Sciences, Clinical Pharmacokinetics, Infectious Diseases +13

A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients

Roy F. Chemaly, Sanjeet Dadwal, Anne Bergeron et al. · Clinical Infectious Diseases · 2019 · 75 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Treatment of Cystitis in Women with a Single Dose of Trimethoprim-Sulfamethoxazole

George W. Counts, Walter E. Stamm, Matt McKevitt et al. · Clinical Infectious Diseases · 1982 · 69 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +11

A Phase 2, Randomized, Placebo-Controlled Study Evaluating Matrix Metalloproteinase-9 Inhibitor, Andecaliximab, in Patients With Moderately to Severely Active Crohn’s Disease

Stefan Schreiber, Corey A. Siegel, Keith Friedenberg et al. · Journal of Crohn s and Colitis · 2018 · 51 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Andecaliximab [Anti-matrix Metalloproteinase-9] Induction Therapy for Ulcerative Colitis: A Randomised, Double-Blind, Placebo-Controlled, Phase 2/3 Study in Patients With Moderate to Severe Disease

William J. Sandborn, Bal Raj Bhandari, Charles Randall et al. · Journal of Crohn s and Colitis · 2018 · 48 citations · Full text

Veterinary Medicine, Pharmacology, Pharmacotherapy +17